CORC  > 西安交通大学
Effectiveness and safety of recombinant human thrombopoietin on treating chemotherapy-induced thrombocytopenia: Data pool analysis of phase II/III and complement multi-center clinical trials
Wu, Quanrui; Zhao, Yongqiang; Chu, Datong; Xu, Binghe; Liao, Meilin; Jiang, Liyan; Xu, Jianmin; Wang, Huaying; Li, Jin; Hou, Mei
刊名Chinese Journal of Cancer Biotherapy
2013
卷号20期号:[db:dc_citation_issue]页码:645-653
关键词Chemotherapy Effectiveness Multi-center clinical trial Randomized controlled trial Recombinant human thrombocytopenia Safety Selfcrossover Solid tumor Thrombocytopenia
ISSN号1007-385X
DOI[db:dc_identifier_doi]
URL标识查看原文
WOS记录号[DB:DC_IDENTIFIER_WOSID]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3310664
专题西安交通大学
推荐引用方式
GB/T 7714
Wu, Quanrui,Zhao, Yongqiang,Chu, Datong,et al. Effectiveness and safety of recombinant human thrombopoietin on treating chemotherapy-induced thrombocytopenia: Data pool analysis of phase II/III and complement multi-center clinical trials[J]. Chinese Journal of Cancer Biotherapy,2013,20([db:dc_citation_issue]):645-653.
APA Wu, Quanrui.,Zhao, Yongqiang.,Chu, Datong.,Xu, Binghe.,Liao, Meilin.,...&Jiang, Bin.(2013).Effectiveness and safety of recombinant human thrombopoietin on treating chemotherapy-induced thrombocytopenia: Data pool analysis of phase II/III and complement multi-center clinical trials.Chinese Journal of Cancer Biotherapy,20([db:dc_citation_issue]),645-653.
MLA Wu, Quanrui,et al."Effectiveness and safety of recombinant human thrombopoietin on treating chemotherapy-induced thrombocytopenia: Data pool analysis of phase II/III and complement multi-center clinical trials".Chinese Journal of Cancer Biotherapy 20.[db:dc_citation_issue](2013):645-653.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace